{"pmid":32504046,"title":"Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.","text":["Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.","Nat Biotechnol","Eroshenko, Nikolai","Gill, Taylor","Keaveney, Marianna K","Church, George M","Trevejo, Jose M","Rajaniemi, Hannu","32504046"],"journal":"Nat Biotechnol","authors":["Eroshenko, Nikolai","Gill, Taylor","Keaveney, Marianna K","Church, George M","Trevejo, Jose M","Rajaniemi, Hannu"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504046","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41587-020-0577-1","topics":["Mechanism","Treatment"],"weight":1,"_version_":1668892488326184960,"score":9.490897,"similar":[{"pmid":32298458,"title":"Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?","text":["Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?","Swiss Med Wkly","Negro, Francesco","32298458"],"journal":"Swiss Med Wkly","authors":["Negro, Francesco"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298458","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.4414/smw.2020.20249","topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138493258039298,"score":65.983665},{"pmid":32428113,"title":"Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE).","text":["Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE).","The world is currently facing a serious SARS-CoV-2 infection pandemic. </mac_aq>This virus is a new isolate of coronavirus, and the current infection crisis has surpassed the SARS and MERS epidemics</mac_aq> that occurred in 2002 and 2013, respectively. SARS-CoV-2 has currently infected more than 142,000 people, causing </mac_aq>5,000 deaths and spreading across more than 130 </mac_aq>countries worldwide. The spreading capacity of the virus clearly demonstrates the potential threat </mac_aq>of respiratory viruses to human health, thereby reiterating to the governments around the world that preventive </mac_aq>health policies and scientific research are pivotal to overcoming the crisis. Coronavirus disease (COVID-19) causes flu-like symptoms in most cases. However, approximately 15% of the patients need hospitalization, and 5% require assisted ventilation, depending on the cohorts studied. What is intriguing, however, is the higher susceptibility of the elderly, especially individuals who are older than 60 years of age, and have comorbidities, including hypertension, diabetes, and heart disease. In fact, the death rate in this group may be up to 10-12%. Interestingly, children are somehow less susceptible and are not considered as a risk group. Therefore, in this review, we discuss some possible molecular and cellular mechanisms by virtue of which the elderly subjects may be more susceptible to severe COVID-19. Toward this, we raise two main </mac_aq>points, i) increased ACE-2 expression in pulmonary and heart tissues in users of chronic angiotensin 1 </mac_aq>receptor (AT1R) blockers; and ii) antibody-dependent enhancement (ADE) after previous exposure to other circulating coronaviruses. We believe that these points are pivotal for a better understanding of the pathogenesis of severe COVID-19, and must be carefully addressed by physicians and scientists in the field.","Clinics (Sao Paulo)","Peron, Jean Pierre Schatzmann","Nakaya, Helder","32428113"],"abstract":["The world is currently facing a serious SARS-CoV-2 infection pandemic. </mac_aq>This virus is a new isolate of coronavirus, and the current infection crisis has surpassed the SARS and MERS epidemics</mac_aq> that occurred in 2002 and 2013, respectively. SARS-CoV-2 has currently infected more than 142,000 people, causing </mac_aq>5,000 deaths and spreading across more than 130 </mac_aq>countries worldwide. The spreading capacity of the virus clearly demonstrates the potential threat </mac_aq>of respiratory viruses to human health, thereby reiterating to the governments around the world that preventive </mac_aq>health policies and scientific research are pivotal to overcoming the crisis. Coronavirus disease (COVID-19) causes flu-like symptoms in most cases. However, approximately 15% of the patients need hospitalization, and 5% require assisted ventilation, depending on the cohorts studied. What is intriguing, however, is the higher susceptibility of the elderly, especially individuals who are older than 60 years of age, and have comorbidities, including hypertension, diabetes, and heart disease. In fact, the death rate in this group may be up to 10-12%. Interestingly, children are somehow less susceptible and are not considered as a risk group. Therefore, in this review, we discuss some possible molecular and cellular mechanisms by virtue of which the elderly subjects may be more susceptible to severe COVID-19. Toward this, we raise two main </mac_aq>points, i) increased ACE-2 expression in pulmonary and heart tissues in users of chronic angiotensin 1 </mac_aq>receptor (AT1R) blockers; and ii) antibody-dependent enhancement (ADE) after previous exposure to other circulating coronaviruses. We believe that these points are pivotal for a better understanding of the pathogenesis of severe COVID-19, and must be carefully addressed by physicians and scientists in the field."],"journal":"Clinics (Sao Paulo)","authors":["Peron, Jean Pierre Schatzmann","Nakaya, Helder"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428113","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.6061/clinics/2020/e1912","locations":["Shedding"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667352728866652160,"score":63.046066},{"pmid":32361326,"title":"Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.","text":["Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.","J Clin Virol","Fleming, Andrew B","Raabe, Vanessa","32361326"],"journal":"J Clin Virol","authors":["Fleming, Andrew B","Raabe, Vanessa"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361326","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jcv.2020.104388","topics":["Treatment"],"weight":1,"_version_":1666138495550226432,"score":47.07228},{"pmid":32438257,"title":"SARS-CoV-2 and enhancing antibodies.","text":["SARS-CoV-2 and enhancing antibodies.","J Clin Virol","Denner, Joachim","32438257"],"journal":"J Clin Virol","authors":["Denner, Joachim"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438257","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jcv.2020.104424","weight":0,"_version_":1667521393590272000,"score":42.68733},{"pmid":32165541,"pmcid":"PMC7132130","title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.","text":["Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.","A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently spreading across many countries globally. Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2. Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2.","Proc Natl Acad Sci U S A","Matsuyama, Shutoku","Nao, Naganori","Shirato, Kazuya","Kawase, Miyuki","Saito, Shinji","Takayama, Ikuyo","Nagata, Noriyo","Sekizuka, Tsuyoshi","Katoh, Hiroshi","Kato, Fumihiro","Sakata, Masafumi","Tahara, Maino","Kutsuna, Satoshi","Ohmagari, Norio","Kuroda, Makoto","Suzuki, Tadaki","Kageyama, Tsutomu","Takeda, Makoto","32165541"],"abstract":["A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently spreading across many countries globally. Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2. Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2."],"journal":"Proc Natl Acad Sci U S A","authors":["Matsuyama, Shutoku","Nao, Naganori","Shirato, Kazuya","Kawase, Miyuki","Saito, Shinji","Takayama, Ikuyo","Nagata, Noriyo","Sekizuka, Tsuyoshi","Katoh, Hiroshi","Kato, Fumihiro","Sakata, Masafumi","Tahara, Maino","Kutsuna, Satoshi","Ohmagari, Norio","Kuroda, Makoto","Suzuki, Tadaki","Kageyama, Tsutomu","Takeda, Makoto"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32165541","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.1073/pnas.2002589117","keywords":["sars-cov-2","tmprss2","veroe6","coronavirus","outbreak"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490648133632,"score":40.90252}]}